Literature DB >> 28221127

Serologic Evidence for MERS-CoV Infection in Dromedary Camels, Punjab, Pakistan, 2012-2015.

Muhammad Saqib, Andrea Sieberg, Muhammad Hammad Hussain, Muhammad Khalid Mansoor, Ali Zohaib, Erik Lattwein, Marcel Alexander Müller, Christian Drosten, Victor Max Corman.   

Abstract

Dromedary camels from Africa and Arabia are an established source for zoonotic Middle East respiratory syndrome coronavirus (MERS-CoV) infection among humans. In Pakistan, we found specific neutralizing antibodies in samples from 39.5% of 565 dromedaries, documenting significant expansion of the enzootic range of MERS-CoV to Asia.

Entities:  

Keywords:  Africa; Asia; Bactrian; MERS-CoV; Middle East respiratory syndrome; One Health; Pakistan; RNA viruses; animal reservoir; antimicrobial resistance; camels; coronavirus; dromedary; livestock; neutralizing antibodies; serology; viruses; zoonoses

Mesh:

Year:  2017        PMID: 28221127      PMCID: PMC5382745          DOI: 10.3201/eid2303.161285

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


The Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic pathogen that causes severe respiratory disease in humans. Dromedary camels (Camelus dromedarius), which have 1 hump on their backs, have been identified as an animal reservoir and source of human MERS-CoV infection (). Reports document widespread infection of these camels on the Arabian Peninsula and parts of Africa (–). Besides these regions, dromedaries are also native to several countries in Asia. A study in Kazakhstan found no evidence for MERS-CoV infection in dromedaries (). Absence of MERS-CoV infection in dromedary camels in Asia could mean a vulnerable animal reservoir at risk for de novo introduction by sporadic contact (e.g., by trade) with dromedaries from MERS-CoV endemic areas. Pakistan is 1 of 8 countries globally, and the only country outside Africa, that has a dromedary population exceeding 1 million animals (FAOSTAT database; http://faostat3.fao.org). Because of the limited capacities for routine MERS-CoV surveillance and a considerable human population size in countries in northeastern Asia, targeted investigation of the MERS-CoV infection status is of interest for global public health agencies. In this study, we examined dromedaries from Pakistan for exposure to MERS-CoV. We tested 565 serum samples, which we collected from 348 female and 217 male animals by using a convenience sampling strategy in 9 districts of Punjab, eastern Pakistan, during 2012–2015. The median age of the animals was 5 years. The testing algorithm comprised 2 antibody detection methods (,). MERS-CoV IgG was detected by using a MERS-CoV camel antibody ELISA (EUROIMMUN, Lübeck, Germany). We tested all serum samples that exceeded a cutoff of 0.4, validated in previous studies (,), by using a microneutralization (MN) test for confirmation (). Only serum samples with neutralizing activity >1:80 were considered MERS-CoV antibody–positive. A total of 315 (55.8%) of 565 camel serum samples exceeded the ELISA signal cutoff (Table). Of these, 223 (39.5%) were confirmed by using MN. We identified MERS-CoV neutralizing antibodies in camels sampled in all study years and in nearly all regions except the district of Chiniot (Table). The rate of neutralizing antibody–positive camel samples ranged from 82.9% in Rahim Yar Khan to 24.1% in the Jhang district (Table).
Table

Detection of Middle East respiratory syndrome coronavirus antibodies in dromedary camels from different districts of Punjab Province, Pakistan, 2012–2015*

District
Year of sampling†
No. animals tested
ELISA
MN
No. positive
Detection rate, % (95% CI)
No. positive
Detection rate, % (95% CI)
Chiniot2012, 201423417.4 (5–38.8)00 (0.0–14.8)
Faisalabad2012, 2013, 2015664568.2 (55.6–79.1)3248.5 (36.0–61.1)
Jhang2012, 2013, 20152207935.9 (29.6–42.6)5324.1 (18.6–30.3)
Bhakkar2012885157.9 (47–68.4)3640.9 (30.5–51.9)
Layyah201213969.2 (38.6–90.9)430.8 (9.1–61.4)
Muzaffargarh2012, 2013402665 (48.3–79.4)1537.5 (22.7–54.2)
Bahawalpur2015292689.7 (72.6–97.8)2172.4 (52.8–87.3)
Lodhran2014514282.4 (69.1–91.6)3364.7 (50.1–77.6)
Rahim Yar Khan
2012
35
33
94.3 (80.8–99.3)

29
82.9 (66.4–93.4)
Total56531555.8 (51.5–59.9)22339.5 (35.4–43.6)

*Serum samples were tested at a dilution of 1:100; MNT was done in a microtiter plate format in duplicate at a dilution of 1:80. ELISA ratio >0.4 and MN >1:80 were considered positive. MN, microneutralization.
†Samples from all years, except the samples from 2012 and 2014 from Chiniot, were MN positive.

*Serum samples were tested at a dilution of 1:100; MNT was done in a microtiter plate format in duplicate at a dilution of 1:80. ELISA ratio >0.4 and MN >1:80 were considered positive. MN, microneutralization.
†Samples from all years, except the samples from 2012 and 2014 from Chiniot, were MN positive. By using a merged dataset comprising all regions, we correlated seropositivity to animal age and sex. Sex-dependent differences suggested pronounced seropositivity in male animals, but differences were not significant (p>0.067; Technical Appendix Table). Seropositivity increased with age: samples from more than half (51.1%) of all animals >5 years of age and less than one third (29.2%) of animals <2 years of age tested positive (p<0.001; online Technical Appendix Table). These age-dependent differences are similar to those found in previous studies (,) and can be explained by long-lasting immune response or regular re-exposure after initial MERS-CoV infection. The finding of antibodies in young camels born in Pakistan suggests ongoing circulation of MERS-CoV in the country. Bactrian camels (C. bactrianus), which have 2 humps on their backs, are also native to Central and East Asia. Studies of these camels in China and Mongolia, as well as dromedary and Bactrian camels in southern Kazakhstan, uniformly reported absence of MERS-CoV during 2014–2015 (,,). However, dromedaries may become sources of infection for Bactrian camels that are susceptible to MERS-CoV and present in this vast geographic range. The possibility of cross-species transmission within the order of camelids has been documented by a study that found signs of MERS-CoV infection in alpacas (Vicugna pacos) that shared a barn with dromedaries in Qatar (). The absence of MERS-CoV in camelid populations in northeastern parts of Asia (Mongolia, Kazakhstan, and China) is compatible with the view that the spread of MERS-CoV from Africa into Asia may be a recent development. However, other explanations, including resistance to infection by Bactrian camels, are possible. Studies of susceptibility should be conducted to clarify whether Bactrian camels in Asia could act as a naïve reservoir population in the future. Based on MERS-CoV antibodies in dromedary camels, our data suggest a risk for human exposure in Punjab, Pakistan, that is similar to risks in Africa and the Arabian Peninsula. Of note, Punjab shares a border with the state of Rajasthan in India, which harbors that country’s largest dromedary population. A similar risk for human exposure is likely for this part of India. However, findings of antibodies against MERS-CoV in migrant workers from these areas should be interpreted with caution because these workers often employed in Arabian countries. For Pakistan, our data largely exclude the scenario of a widely susceptible animal reservoir population in which de novo introduction of MERS-CoV could start an epizootic that could lead to spillover epidemics among humans.

Technical Appendix

Univariate analysis of potential risk factors associated with Middle East respiratory syndrome coronavirus seropositivity in dromedary camels in Punjab, Pakistan.
  9 in total

1.  Acute middle East respiratory syndrome coronavirus infection in livestock Dromedaries, Dubai, 2014.

Authors:  Ulrich Wernery; Victor M Corman; Emily Y M Wong; Alan K L Tsang; Doreen Muth; Susanna K P Lau; Kamal Khazanehdari; Florian Zirkel; Mansoor Ali; Peter Nagy; Jutka Juhasz; Renate Wernery; Sunitha Joseph; Ginu Syriac; Shyna K Elizabeth; Nissy Annie Georgy Patteril; Patrick C Y Woo; Christian Drosten
Journal:  Emerg Infect Dis       Date:  2015-06       Impact factor: 6.883

2.  Absence of MERS-Coronavirus in Bactrian Camels, Southern Mongolia, November 2014.

Authors:  Samuel M S Chan; Batchuluun Damdinjav; Ranawaka A P M Perera; Daniel K W Chu; Bodisaikhan Khishgee; Bazarragchaa Enkhbold; Leo L M Poon; Malik Peiris
Journal:  Emerg Infect Dis       Date:  2015-07       Impact factor: 6.883

3.  Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013.

Authors:  Ziad A Memish; Matthew Cotten; Benjamin Meyer; Simon J Watson; Abdullah J Alsahafi; Abdullah A Al Rabeeah; Victor Max Corman; Andrea Sieberg; Hatem Q Makhdoom; Abdullah Assiri; Malaki Al Masri; Souhaib Aldabbagh; Berend-Jan Bosch; Martin Beer; Marcel A Müller; Paul Kellam; Christian Drosten
Journal:  Emerg Infect Dis       Date:  2014-06       Impact factor: 6.883

4.  Geographic distribution of MERS coronavirus among dromedary camels, Africa.

Authors:  Chantal B E M Reusken; Lilia Messadi; Ashenafi Feyisa; Hussaini Ularamu; Gert-Jan Godeke; Agom Danmarwa; Fufa Dawo; Mohamed Jemli; Simenew Melaku; David Shamaki; Yusuf Woma; Yiltawe Wungak; Endrias Zewdu Gebremedhin; Ilse Zutt; Berend-Jan Bosch; Bart L Haagmans; Marion P G Koopmans
Journal:  Emerg Infect Dis       Date:  2014-08       Impact factor: 6.883

5.  MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997.

Authors:  Marcel A Müller; Victor Max Corman; Joerg Jores; Benjamin Meyer; Mario Younan; Anne Liljander; Berend-Jan Bosch; Erik Lattwein; Mosaad Hilali; Bakri E Musa; Set Bornstein; Christian Drosten
Journal:  Emerg Infect Dis       Date:  2014-12       Impact factor: 6.883

6.  Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992-2013.

Authors:  Victor M Corman; Joerg Jores; Benjamin Meyer; Mario Younan; Anne Liljander; Mohammed Y Said; Ilona Gluecks; Erik Lattwein; Berend-Jan Bosch; Jan Felix Drexler; Set Bornstein; Christian Drosten; Marcel A Müller
Journal:  Emerg Infect Dis       Date:  2014-08       Impact factor: 6.883

7.  MERS-CoV Infection of Alpaca in a Region Where MERS-CoV is Endemic.

Authors:  Chantal B E M Reusken; Chrispijn Schilp; V Stalin Raj; Erwin De Bruin; Robert H G Kohl; Elmoubasher A B A Farag; Bart L Haagmans; Hamad Al-Romaihi; Francois Le Grange; Berend-Jan Bosch; Marion P G Koopmans
Journal:  Emerg Infect Dis       Date:  2016-06-15       Impact factor: 6.883

8.  Absence of Middle East Respiratory Syndrome Coronavirus in Camelids, Kazakhstan, 2015.

Authors:  Eve Miguel; Ranawaka A P M Perera; Almagul Baubekova; Véronique Chevalier; Bernard Faye; Nurlan Akhmetsadykov; Chun Yin Ng; François Roger; Malik Peiris
Journal:  Emerg Infect Dis       Date:  2016-03       Impact factor: 6.883

9.  Absence of Middle East respiratory syndrome coronavirus in Bactrian camels in the West Inner Mongolia Autonomous Region of China: surveillance study results from July 2015.

Authors:  Renqiang Liu; Zhiyuan Wen; Jinling Wang; Jinying Ge; Hualan Chen; Zhigao Bu
Journal:  Emerg Microbes Infect       Date:  2015-12-02       Impact factor: 7.163

  9 in total
  26 in total

Review 1.  Major bat-borne zoonotic viral epidemics in Asia and Africa: A systematic review and meta-analysis.

Authors:  Shahneaz Ali Khan; Mohammed Ashif Imtiaz; Md Mazharul Islam; Abu Zubayer Tanzin; Ariful Islam; Mohammad Mahmudul Hassan
Journal:  Vet Med Sci       Date:  2022-05-10

Review 2.  An Opportunistic Pathogen Afforded Ample Opportunities: Middle East Respiratory Syndrome Coronavirus.

Authors:  Ian M Mackay; Katherine E Arden
Journal:  Viruses       Date:  2017-12-02       Impact factor: 5.048

3.  MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015.

Authors:  Pyoeng Gyun Choe; R A P M Perera; Wan Beom Park; Kyoung-Ho Song; Ji Hwan Bang; Eu Suk Kim; Hong Bin Kim; Long Wei Ronald Ko; Sang Won Park; Nam-Joong Kim; Eric H Y Lau; Leo L M Poon; Malik Peiris; Myoung-Don Oh
Journal:  Emerg Infect Dis       Date:  2017-07-15       Impact factor: 6.883

4.  Middle East Respiratory Syndrome Coronavirus Antibodies in Dromedary Camels, Bangladesh, 2015.

Authors:  Ariful Islam; Jonathan H Epstein; Melinda K Rostal; Shariful Islam; Mohammed Ziaur Rahman; Mohammed Enayet Hossain; Mohammed Salim Uzzaman; Vincent J Munster; Malik Peiris; Meerjady Sabrina Flora; Mahmudur Rahman; Peter Daszak
Journal:  Emerg Infect Dis       Date:  2018-05       Impact factor: 6.883

5.  Experimental infection of dromedaries with Middle East respiratory syndrome-Coronavirus is accompanied by massive ciliary loss and depletion of the cell surface receptor dipeptidyl peptidase 4.

Authors:  Ann-Kathrin Haverkamp; Annika Lehmbecker; Ingo Spitzbarth; Widagdo Widagdo; Bart L Haagmans; Joaquim Segalés; Julia Vergara-Alert; Albert Bensaid; Judith M A van den Brand; Albert D M E Osterhaus; Wolfgang Baumgärtner
Journal:  Sci Rep       Date:  2018-06-27       Impact factor: 4.379

6.  Global status of Middle East respiratory syndrome coronavirus in dromedary camels: a systematic review.

Authors:  R S Sikkema; E A B A Farag; Mazharul Islam; Muzzamil Atta; C B E M Reusken; Mohd M Al-Hajri; M P G Koopmans
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

7.  An updated roadmap for MERS-CoV research and product development: focus on diagnostics.

Authors:  Cassandra Kelly-Cirino; Laura T Mazzola; Arlene Chua; Christopher J Oxenford; Maria D Van Kerkhove
Journal:  BMJ Glob Health       Date:  2019-02-01

8.  Lack of serological evidence of Middle East respiratory syndrome coronavirus infection in virus exposed camel abattoir workers in Nigeria, 2016.

Authors:  Ray Ty So; Ranawaka Apm Perera; Jamiu O Oladipo; Daniel Kw Chu; Sulyman A Kuranga; Kin-Ho Chan; Eric Hy Lau; Samuel Ms Cheng; Leo Lm Poon; Richard J Webby; Malik Peiris
Journal:  Euro Surveill       Date:  2018-08

9.  Reported Direct and Indirect Contact with Dromedary Camels among Laboratory-Confirmed MERS-CoV Cases.

Authors:  Romy Conzade; Rebecca Grant; Mamunur Rahman Malik; Amgad Elkholy; Mohamed Elhakim; Dalia Samhouri; Peter K Ben Embarek; Maria D Van Kerkhove
Journal:  Viruses       Date:  2018-08-13       Impact factor: 5.048

Review 10.  Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain.

Authors:  Yusen Zhou; Yang Yang; Jingwei Huang; Shibo Jiang; Lanying Du
Journal:  Viruses       Date:  2019-01-14       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.